Sanofi Pasteur has announced a
new Phase III clinical trial program
called CDiffense which is now
recruiting volunteers in Australia.
CDiffense is a global trial of a
clostridium difficile vaccine involving
15,000 adults in 17 countries.
The vaccine may be an effective
way to prevent the transmission
of the potentially life-threatening
bacterium in healthcare settings.
Pharmacists are encouraged to
identify suitable candidates, who
are those aged over 50 who have
had at least two hospital stays and
systemic antibiotics in the last year.
See www.cdiffense.org.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.